Pdt Partners, LLC Quanterix Corp Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$11.16 - $23.65 $209,919 - $444,856	-18,810 Reduced 51.08%	18,012 $406,000
Q1 2023 May 15, 2023	BUY	$10.12 - $14.91 $189,719 - $279,517	18,747 Added 103.72%	36,822 $414,000
Q4 2022 Feb 14, 2023	SELL	$8.75 - $14.02 $7,708 - $12,351	-881 Reduced 4.65%	18,075 $250,000
Q3 2022 Nov 14, 2022	BUY	$7.46 - $19.28 $141,411 - $365,471	18,956 New	18,956 $209,000
Q2 2021 Aug 16, 2021	SELL	$43.3 - $67.17 $470,411 - $729,734	-10,864 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$44.11 - $90.64 $180,851 - $371,624	4,100 Added 60.62%	10,864 $635,000
Q4 2020 Feb 16, 2021	BUY	$33.89 - $49.88 $229,231 - $337,388	6,764 New	6,764 $315,000

157

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $348M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.